Today: August 15, 2018, 8:40 am
  
Health

Drug Abuse Treatment Market to Surpass US$ 26.3 Bn Threshold by 2026

Coherent Market Insights
Coherent Market Insights
Drug Abuse Treatment Market was valued at US$ 13.4 Bn in 2017 and is projected to exhibit a CAGR of 7.8% over the forecast period (2018 – 2026)

 

PR-Inside.com: 2018-08-10 06:15:52
(EMAILWIRE.COM, August 06, 2018 ) Global Drug Abuse Treatment Market, by Abuse Type (Alcohol Dependence, Tobacco/Nicotine Addiction, and Opioid Addiction), by Drug Type (Disulfiram, Acamprosate, Naltrexone, Methadone, Buprenorphine, Nicotine Addiction Treatment ((Nicotine Replacement Treatment (Nicotine Patch, Nicotine Gum, Nicotine Lozenge, Nicotine Spray, and Nicotine Inhaler)) ((Non-Nicotine Medication, (Bupropion, and Varenicline)), and Others), by Distribution Channel (Hospital, Retail Pharmacy, and Online Pharmacy) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 13.4 Bn in 2017, and is projected to exhibit a CAGR of 7.8% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights. Increasing launches of novel drugs for treatment of drug abuse in market is expected to drive the global drug abuse treatment market growth in near future.


For instance, in 2015, Mylan N.V. launched its new drugs Disulfiram Tablets USP, 250 mg and 500 mg in the U.S. market, drugs Disulfiram Tablets USP is a generic version of Odyssey Pharmaceutical's Antabuse. In 2017, Glenmark Pharmaceuticals launched its new nicotine replacement therapy namely Kwitz in India. Kwitz is a nicotine gum and is available in two variants Kwitz 2 mg and Kwitz 4 mg. Kwitz 2 mg is for the smokers having less than 20 cigarettes per day and Kwitz 4 mg is for those who smoke more than 20 cigarettes per day.

In April 2018, Lil' Drug Store Products Inc. launched its Nicotac brand nicotine gum in market. Lil' Drug Store Products Inc. has launched its Nicotac in two nicotine strengths (2 mg and 4 mg nicotine polarcrilex). In 2017, Cipla Health, an arm of Cipla Limited launched a new Nicotex Nicotine Patches. Nicotex Nicotine Patches are skin/transdermal patches, which helps to quit smoking in 12 months. Company has launched its patches in 3 strengths 21 mg, 14 mg, and 7 mg. 21 mg patch is for one who smoke more than 20 cigarette a day, 14 mg is for those who smoke less that 20 cigarette a day

Browse 23 Market Data Tables and 26 Figures spread through 180 Pages and in-depth TOC on Drug Abuse Treatment Market By Abuse Type (Alcohol Dependence, Tobacco/Nicotine Addiction, and Opioid Addiction), By Drug Type (Disulfiram, Acamprosate, Naltrexone, Methadone, Buprenorphine, Nicotine Addiction Treatment ((Nicotine Replacement Treatment (Nicotine Patch, Nicotine Gum, Nicotine Lozenge, Nicotine Spray, Nicotine Inhaler)) ((Non-Nicotine Medication, (Bupropion, and Varenicline)), and Others), By Distribution Channel (Hospital, Retail Pharmacy, and Online Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026

Latest trends and insights prevalent in the Drug Abuse Treatment Market:

www.coherentmarketinsights.com/market-insight/drug-abuse-treatme ..

Furthermore, increasing prevalence of drug abuse and dependence in key regions are expected to increase the demand for its treatment and management drugs in near future. For instance, according to the Substance Abuse and Mental Health Services Administration (SAMHSA), around 830,000 people in the U.S. used heroin in 2015, which is more than double the number from 2002. Such increasing rates of drugs abuse are expected to fuel growth of the global drug abuse treatment market in near future.

Click here to buy this Market Intelligence Report:

www.coherentmarketinsights.com/insight/buy-now/2011

Click the Link below to have a look at a Sample before buying:

www.coherentmarketinsights.com/insight/request-sample/2011

Request Sample

Key Takeaways of the Drug Abuse Treatment Market:

The global drug abuse treatment market is expected to exhibit a CAGR of 7.8% over the forecast period (2018 – 2026), owing to frequent product launches, approval and robust pipeline of novel biopharmaceutical products

North America held the dominant position in the global drug abuse treatment market and is expected to retain its dominance over the forecast period (2018 – 2026). This is due to the high rates of drug abuse in region, which are expected to increase demand for its treatment drugs over the forecast period. For instance, according to the data published by National Institute of Alcohol abuse and Alcoholism in 2015, around 15.1 million adults ages 18 and older (6.2 percent of this age group) are suffering from Alcohol Use Disorder. This includes 9.8 million men (8.4 percent of men in this age group) and 5.3 million women.

Asia Pacific is expected to witness significant growth over the forecast period due to increasing launches of novel drugs by key players in the region. For instance, in 2017, Glenmark Pharmaceuticals launched a new Kwitz is a nicotine gum in India.

Major players operating in the drug abuse treatment market include Cipla Limited, Glenmark Pharmaceuticals, Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil' Drug Store Products Inc., Indivior Plc., Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., and British American Tobacco Plc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com



This is a press release. Press release distribution and press release services by EmailWire.Com: www.emailwire.com/us-press-release-distribution.php.

Press Information


Published by
GroupWeb EmailWire.Com
281-645-4086
e-mail
www.emailwire.com



# 847 Words
Related Articles
More From The Author
Propylene Market Demand to Surpass 140 million [..]
(EMAILWIRE.COM, August 06, 2018 ) According to a Global Propylene Market Report by Derivative (Polypropylene, Propylene oxide, [..]
Primary Sclerosing Cholangitis Market to Reach US$ [..]
(EMAILWIRE.COM, July 30, 2018 ) Global Primary Sclerosing Cholangitis Market, by Drug (BT1023, GS-9674, NGM282, OCA, LUM001, and [..]
Picture Archiving and Communication System (PACS) Market [..]
(EMAILWIRE.COM, July 30, 2018 ) The Global Picture Archiving and Communication System (PACS) Market, by Deployment (Web Based, [..]
Electroceutical Devices Market to Surpass US$ 33 [..]
(EMAILWIRE.COM, July 30, 2018 ) The Global Electroceutical Devices Market, by Product (Cardiac Pacemakers, Implantable Cardioverter Defibrillators, [..]
Smart Healthcare Products Market is Expected to [..]
(EMAILWIRE.COM, July 23, 2018 ) The Global Smart Healthcare Products Market, by Product Type (Electronic Health Record, Smart [..]
 
More From Health
Sponsors Recommend Novotech for CRO Leadership Award
SYDNEY, Aug 9, 2018 - (ACN Newswire) - Asia-Pacific specialist CRO Novotech has been awarded the "Exceeded Customer Expectations" [..]
Nurse Staffing Agency Website Focuses on Services; [..]
Elkhart, IN; August 1, 2018 – Excellent Nursing Services, Inc. (ENS) has announced the launch of the agency’s website highlighting [..]
Ascletis-developed Ganovo Acquired Extraordinary Achievement
Ganovo Phase III Clinical Study Won the Top Award at the Infectious Disease National Congress of Chinese Medical Association HONG [..]
Novotech Partners with Asian Eye Institute
SYDNEY, July 17, 2018 - (ACN Newswire) - Asia-Pacific specialist CRO Novotech announced today it has partnered with the Asian [..]
Natures Natural India Offers Superior-Quality Attar for [..]
City, State, Date – Attar is the fragrant oil which is obtained by the process of ‘steam distillation’ of the [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.